Related references
Note: Only part of the references are listed.LMO3 interacts with p53 and inhibits its transcriptional activity
Steven Larsen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q-Neuroblastoma
Patrick G. Buckley et al.
CLINICAL CANCER RESEARCH (2010)
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
Sara De Brouwer et al.
CLINICAL CANCER RESEARCH (2010)
Prognostic Impact of Gene Expression-Based Classification for Neuroblastoma
Andre Oberthuer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
M. Fischer et al.
ONCOGENE (2010)
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
Kaisa Thorell et al.
BMC MEDICAL GENOMICS (2009)
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
P. F. Ambros et al.
BRITISH JOURNAL OF CANCER (2009)
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma
Isabella Eckerle et al.
CANCER LETTERS (2009)
Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
Lorena Passoni et al.
CANCER RESEARCH (2009)
Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds
Katleen De Preter et al.
CLINICAL CANCER RESEARCH (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3
Thomas Y. Y. Leon et al.
JOURNAL OF PEDIATRIC SURGERY (2009)
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Joelel Vermeulen et al.
LANCET ONCOLOGY (2009)
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Caren et al.
BIOCHEMICAL JOURNAL (2008)
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors:: Four cases of homozygous deletions of the CDKN2A gene
Helena Caren et al.
BMC GENOMICS (2008)
Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and Game Theory
Domenico Albino et al.
CANCER (2008)
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma
Jan J. Molenaar et al.
CANCER RESEARCH (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann et al.
GENOME BIOLOGY (2008)
ArrayCGH-based classification of neuroblastoma into genomic subgroups
Evi Michels et al.
GENES CHROMOSOMES & CANCER (2007)
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease
Andre Oberthuer et al.
CANCER LETTERS (2007)
Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes
Patrick Warnat et al.
BMC CANCER (2007)
High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene
Prakash N. Nair et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma
Irene Y. Cheung et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Customized oligonucleotide microarray gene expression based classification of neuroblastoma patients outperforms current clinical risk stratification
Andre Oberthuer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification
Shahab Asgharzadeh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome
Matthias Fischer et al.
CLINICAL CANCER RESEARCH (2006)
Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: A report from the children's oncology group
Michal A. Miller et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number
Qun Wang et al.
CANCER RESEARCH (2006)
Oncogenic rearrangements of the NTRK1/NGF receptor
MA Pierotti et al.
CANCER LETTERS (2006)
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
Katleen De Preter et al.
GENOME BIOLOGY (2006)
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
A Schramm et al.
ONCOGENE (2005)
LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma
M Aoyama et al.
CANCER RESEARCH (2005)
Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas
M Ohira et al.
CANCER CELL (2005)
Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q
L McArdle et al.
CARCINOGENESIS (2004)
Germline PHOX2B mutation in hereditary neuroblastoma
YP Mosse et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Rearrangements and increased expression of cyclin DI (CCNDI) in neuroblastoma
JJ Molenaar et al.
GENES CHROMOSOMES & CANCER (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
EJ Yeoh et al.
CANCER CELL (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
A Islam et al.
ONCOGENE (2000)
Share Paper
